Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29593270 | 1.00 | L3MBTL1 (0.61) | L3MBTL1ALDH1A1KDM4ELMNANPC1 | |
| Hydrochloric Acid SCHEMBL1852816 | 0.98 | L3MBTL1 (0.59) | L3MBTL1ALDH1A1KDM4ELMNANPC1 | |
| Hydrochloric Acid SCHEMBL1852818 | 0.98 | L3MBTL1 (0.59) | L3MBTL1ALDH1A1KDM4ELMNANPC1 | |
| Bromide SCHEMBL10767217 | 0.98 | L3MBTL1 (0.59) | L3MBTL1ALDH1A1KDM4ELMNANPC1 | |
| SCHEMBL5115647 | 0.85 | L3MBTL1 (0.55) | L3MBTL1ALDH1A1KDM4ELMNANPC1 | |
| SCHEMBL18995127 | 0.85 | L3MBTL1 (0.55) | L3MBTL1ALDH1A1KDM4ELMNANPC1 | |
| SCHEMBL844538 | 0.85 | L3MBTL1 (0.50) | L3MBTL1ALDH1A1KDM4ELMNANPC1 | |
| SCHEMBL4670154 | 0.85 | L3MBTL1 (0.50) | L3MBTL1ALDH1A1KDM4ELMNANPC1 | |
| SCHEMBL21618225 | 0.85 | L3MBTL1 (0.50) | L3MBTL1ALDH1A1KDM4ELMNANPC1 | |
| SCHEMBL31303512 | 0.85 | L3MBTL1 (0.50) | L3MBTL1ALDH1A1KDM4ELMNANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12629447-B2 | Shape memory material with chelating system and preparation method thereof | SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY (CN) | 2026-05-19 | — | — | US | claimed |
| US-20240293598-A1 | Shape memory material with chelating system and preparation method thereof | SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY (CN) | 2024-09-05 | — | — | US | claimed |
| EP-3839092-A1 | METHOD FOR ACTIVATING AT LEAST ONE SURFACE, ACTIVATION COMPOSITION, AND USE OF THE ACTIVATION COMPOSITION TO ACTIVATE A SURFACE FOR ELECTROLESS PLATING | ATOTECH Deutschland GmbH (DE) | 2021-06-23 | — | — | EP | claimed |
| CN-101514201-A | Preparation method for (4,7-cis)-octahydro-pyrrolo[3,4-b]pyridine and moxifolxacin | ZHEJIANG HISOAR PHARMACEUTICAL (CN) | 2009-08-26 | — | — | CN | claimed |
| US-20040023890-A1 | Drugs for diabetes | NICOX S.A. (FR) | 2004-02-05 | — | — | US | claimed |
| EP-1324974-A2 | DRUGS FOR DIABETES | Nicox S.A. (FR) | 2003-07-09 | — | — | EP | claimed |
| EP-1232145-B1 | METHOD FOR PRODUCING HYDROXYMETHYLPYRIDINES | DSM FINE CHEM AUSTRIA GMBH (AT) | 2003-07-02 | — | — | EP | claimed |
| WO-2002030867-A2 | DRUGS FOR DIABETES | NICOX S.A. (FR) | 2002-04-18 | — | — | WO | claimed |
| EP-0533132-B1 | Process for the oxidation of hydroxymethylpyridine derivatives to pyridine carboxylic acid derivatives | HOECHST AG (DE) | 1994-11-02 | — | — | EP | claimed |
| JP-6287287-A | — | — | None | — | — | JP | disclosed |
| US-12629447-B2 | Shape memory material with chelating system and preparation method thereof | SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY (CN) | 2026-05-19 | — | — | US | disclosed |
| US-20250353836-A1 | N-(HYDROXYALKYL (HETERO)ARYL) TETRAHYDROFURAN CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS | VERTEX PHARMA (US) | 2025-11-20 | — | — | US | disclosed |
| EP-3774787-B1 | A COMPOUND, A REACTION PRODUCT OF SAID COMPOUND AND PRODUCTION METHODS THEREOF | AGENCY SCIENCE TECH & RES (SG) | 2025-08-20 | — | — | EP | disclosed |
| CN-119978334-A | Method for synthesizing water-soluble polyester without catalyst | 浙江理工大学 | 2025-05-13 | — | — | CN | disclosed |
| US-4960882-A | CROWN COMPOUNDS; USEFUL AS LIGANDS | BRIGHAM YOUNG UNIVERSITY (US) | 1990-10-02 | — | — | US | disclosed |
| EP-0326124-A2 | A thermoplastic laminated film | Toyo Boseki Kabushiki Kaisha (JP) | 1989-08-02 | — | — | EP | disclosed |
| EP-0298101-A1 | THIOL-REACTIVE CROSS-LINKING REAGENTS | CELLTECH LIMITED (GB) | 1989-01-11 | — | — | EP | disclosed |
| EP-0294528-A2 | Proton ionizable macrocyclic compounds and selective competitive separation of desirable metal ions from mixtures thereof with other ions | Bradshaw, Jerald S. (US) | 1988-12-14 | — | — | EP | disclosed |
| WO-1988005433-A1 | THIOL-REACTIVE CROSS-LINKING REAGENTS | CELLTECH LIMITED (GB) | 1988-07-28 | — | — | WO | disclosed |
| EP-0103538-A2 | Copolymers of vinylpyridine, process for their preparation and their use as sulphonate reagents | CIBA-GEIGY AG (CH) | 1984-03-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12629447-B2 | Shape memory material with chelating system and preparation method thereof | TMCO1, ORAI1, BMP2 | L3MBTL1 2562/4885ALDH1A1 4220/4885KDM4E 381/4885 |
| US-20040023890-A1 | Drugs for diabetes | SLC5A2, ADORA2B, UGT2B7 | L3MBTL1 3786/4885ALDH1A1 101/4885KDM4E 3253/4885 |
| US-20250353836-A1 | N-(HYDROXYALKYL (HETERO)ARYL) TETRAHYDROFURAN CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS | TRPV1, SCN2A, SCN2B | L3MBTL1 4523/4885ALDH1A1 1741/4885KDM4E 3320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.